Daniel G.

Daniel Guber is an experienced professional in investment banking and venture capital with a strong background in healthcare and life sciences. Daniel held the position of Off-cycle Analyst in Investment Banking at Pareto Securities, specializing in healthcare ECM, and previously interned at Arctic Asset Management, conducting research on M&A transactions in major pharmaceutical companies. Daniel's venture capital experience includes analyzing over 150 Swedish life science companies at Sound Bioventures. Earlier roles involved business development for cancer patient solutions at Oppioo and management consulting at Comentum focused on healthcare innovation. Daniel's technical expertise was developed as a Laboratory Technician at Polymun Scientific, contributing to mRNA vaccine development, and as a Process Engineer at EV Group. Daniel's academic credentials include a Master of Science in Bioentrepreneurship from Karolinska Institutet, supplemented by courses from prestigious institutions such as Uppsala University and KTH Royal Institute of Technology.